GDNF is important for striatal organization and maintenance of dopamine neurons grown in the presence of the striatum

Neuroscience

Volumn 270, Issue , 2014, Pages 1-11

  Chermenina, M ^a   Schouten, P ^a   Nevalainen, N ^a   Johansson, F ^a   Oradd G ^a   Stromberg I ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

DARPP 32; Dopamine; GDNF; GDNF knockout; Striatum; Substantia nigra

Indexed keywords

CYCLIC AMP; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE; GDNF PROTEIN, MOUSE; PHOSPHOPROTEIN DARPP 32; PPP1R1B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCEPHALON; MOUSE; NERVE CELL GROWTH; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ANIMAL; BRAIN TRANSPLANTATION; C57BL MOUSE; DOPAMINERGIC NERVE CELL; EMBRYOLOGY; FEMALE; GENETICS; GENOTYPING TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; PHYSIOLOGY; SURGERY; TRANSGENIC MOUSE; TRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CORPUS STRIATUM; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINERGIC NEURONS; FEMALE; GENOTYPING TECHNIQUES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MESENCEPHALON; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; TYROSINE 3-MONOOXYGENASE;

EID: 84899138441     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.008     Document Type: Article

References (56)

1. af Bjerkén S., Boger H.A., Nelson M., Hoffer B.J., Granholm A.C., Strömberg I. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res 2007, 1133:10-19.
2. Ai Y., Markesbery W., Zhang Z., Grondin R., Elseberry D., Gerhardt G.A., Gash D.M. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J Comp Neurol 2003, 461:250-261.
3. Airavaara M., Planken A., Gaddnas H., Piepponen T.P., Saarma M., Ahtee L. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur J Neurosci 2004, 20:2336-2344.
4. Andereggen L., Meyer M., Guzman R., Ducray A.D., Widmer H.R. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease. Brain Res 2009, 1276:39-49.
5. Barroso-Chinea P., Cruz-Muros I., Aymerich M.S., Rodriguez-Diaz M., Afonso-Oramas D., Lanciego J.L., Gonzalez-Hernandez T. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Eur J Neurosci 2005, 21:1815-1827.
6. Battaglia G., Molinaro G., Riozzi B., Storto M., Busceti C.L., Spinsanti P., Bucci D., Di Liberto V., Mudo G., Corti C., Corsi M., Nicoletti F., Belluardo N., Bruno V. Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons. PLoS One 2009, 4:e6591.
7. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995, 373:339-341.
8. Björklund L., Strömberg I. Dopaminergic growth patterns induced by striatal and cortical grafts show differences in sensitivity to increased striatal trophic activity induced by haloperidol. J Neurosci Res 1998, 53:165-176.
9. Boger H.A., Middaugh L.D., Huang P., Zaman V., Smith A.C., Hoffer B.J., Tomac A.C., Granholm A.C. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol 2006, 202:336-347.
10. Bourque M.J., Trudeau L.E. GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur J Neurosci 2000, 12:3172-3180.
11. Choi-Lundberg D.L., Bohn M.C. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev Brain Res 1995, 85:80-88.
12. Choi-Lundberg D.L., Lin Q., Chang Y.N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 1997, 275:838-841.
13. Clarkson E.D., Zawada W.M., Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport 1995, 7:145-149.
14. Deglon N., Tseng J.L., Bensadoun J.C., Zurn A.D., Arsenijevic Y., Pereira de Almeida L., Zufferey R., Trono D., Aebischer P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 2000, 11:179-190.
15. Garbayo E., Montero-Menei C.N., Ansorena E., Lanciego J.L., Aymerich M.S., Blanco-Prieto M.J. Effective GDNF brain delivery using microspheres-a promising strategy for Parkinson's disease. J Control Release 2009, 135:119-126.
16. Georgievska B., Jakobsson J., Persson E., Ericson C., Kirik D., Lundberg C. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther 2004, 15:934-944.
17. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003, 9:589-595.
18. Golden J.P., Baloh R.H., Kotzbauer P.T., Lampe P.A., Osborne P.A., Milbrandt J., Johnson E.M. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J Comp Neurol 1998, 398:139-150.
19. Granholm A.-C., Mott J.L., Bowenkamp K., Eken S., Henry S., Hoffer B.J., Lapchak P.A., Palmer M.R., van Horne C., Gerhardt G.A. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 1997, 116:29-38.
20. Hebert M.A., Gerhardt G.A. Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 1997, 282:760-768.
21. Hebert M.A., Van Horne C.G., Hoffer B.J., Gerhardt G.A. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther 1996, 279:1181-1190.
22. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Simpson L.C., et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994, 266:1062-1064.
23. Hennig J., Nauerth A., Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Res Med 1986, 3:823-833.
24. Hidalgo-Figueroa M., Bonilla S., Gutierrez F., Pascual A., Lopez-Barneo J. GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway. J Neurosci 2012, 32:864-872.
25. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 1994, 182:107-111.
26. Janec E., Burke R.E. Naturally occurring cell death during postnatal development of the substantia nigra pars compacta of rat. Mol Cell Neurosci 1993, 4:30-35.
27. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 1995, 672:104-111.
28. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
29. Ledda F., Paratcha G., Sandoval-Guzman T., Ibanez C.F. GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat Neurosci 2007, 10:293-300.
30. Lin L.-F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
31. Lopez-Martin E., Caruncho H.J., Rodriguez-Pallares J., Guerra M.J., Labandeira-Garcia J.L. Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal striatal grafts. J Comp Neurol 1999, 406:199-206.
32. Love S., Plaha P., Patel N.K., Hotton G.R., Brooks D.J., Gill S.S. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 2005, 11:703-704.
33. Maswood N., Grondin R., Zhang Z., Stanford J.A., Surgener S.P., Gash D.M., Gerhardt G.A. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol Aging 2002, 23:881-889.
34. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996, 382:76-79.
35. Nevalainen N., Chermenina M., Rehnmark A., Berglof E., Marschinke F., Stromberg I. Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system. Neuroscience 2010, 171:1357-1366.
36. Olson L., Seiger Å., Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res 1972, 44:283-288.
37. Oo T.F., Kholodilov N., Burke R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 2003, 23:5141-5148.
38. Pascual A., Hidalgo-Figueroa M., Piruat J.I., Pintado C.O., Gomez-Diaz R., Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci 2008, 11:755-761.
39. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol 2005, 57:298-302.
40. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., Sariola H., Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996, 382:73-76.
41. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth, and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 1996, 75:979-985.
42. Schaar D.G., Sieber B.A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in rat brain. Exp Neurol 1993, 124:368-371.
43. Sinclair S.R., Svendsen C.N., Torrs E.M., Martin D., Fawcett J.W., Dunnett S.B. GDNF enhances cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport 1996, 7:2547-2552.
44. Slevin J.T., Gash D.M., Smith C.D., Gerhardt G.A., Kryscio R., Chebrolu H., Walton A., Wagner R., Young A.B. Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J Neurosurg 2007, 106:614-620.
45. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg 2005, 102:216-222.
46. Springer J.E., Mu X., Bergmann L.W., Trojanowski J.Q. Expression of GDNF mRNA in rat and human nervous tissue. Exp Neurol 1994, 127:167-170.
47. Strömberg I., Bjorklund L., Förander P. The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study. Cell Transplant 1997, 6:287-296.
48. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor (GDNF) is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 1993, 124:401-412.
49. Strömberg I., Johansson M. Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts. Exp Brain Res 1994, 101:73-85.
50. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995, 373:335-339.
51. Tomac A., Widenfalk J., Lin L.-F.H., Kohino T., Ebendal T., Hoffer B.J., Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci 1995, 92:8274-8278.
52. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996, 381:785-789.
53. Tsui C.C., Pierchala B.A. The differential axonal degradation of Ret accounts for cell-type-specific function of glial cell line-derived neurotrophic factor as a retrograde survival factor. J Neurosci 2010, 30:5149-5158.
54. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther 2002, 9:381-389.
55. Yurek D.M. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp Neurol 1998, 153:195-202.
56. Zurn A.D., Baetge E.E., Hammang J.P., Tan S.A., Aebischer P. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. NeuroReport 1994, 6:113-118.